News|Articles|June 25, 2025

THC Therapeutics Secures Acquisition, Gains Vertically Integrated Cannabis Portfolio with The Headquarters Group

Author(s)Erin McEvoy

The acquisition is anticipated to provide a foothold in two states and allow for further expansion in additional locations.

In a June 24, 2025, press release, US public company THC Therapeutics (THCT), Inc. announced the full acquisition of The Headquarters Group, Inc. (THG), an Oregon-based holding company with a portfolio of cannabis companies across two states and a combined 2024 revenue of approximately $4.8 million (1). The transaction was valued at $11 million.

“This collaboration of deep expertise from world class cannabis operations management with over 60 years of combined experience will allow us to maximize efficiencies and generate significant revenue for THCT,” stated Scott Cox, CEO of THC Therapeutics Inc., in the press release. “The combined Company will serve as a vertically integrated foundation in the Company’s focused roll-up strategy to acquire industry leading cannabis companies in the cultivation, manufacturing, distribution and nutrients segments within the regulated cannabis industry.”

THCT has been in the industry since 2001, the press release stated. Both THCT and THG managers will operate and manage the combined companies.

“The market is in a great place right now,” added Richard Rowe, CEO of THG. “The cannabis market itself is growing, while the industry that supports that market is in a strong consolidation phase. This is a good place to be for a successful business with proven systems and access to capital. We believe now is a great time to partner with someone like Scott and with a platform like THCT. Investment money has driven the market since its inception. Those who could spend the most money the fastest, were often, temporarily, perceived by the market to be the winners. Now the Era of Efficiency has come, moving forward efficiency, more and more, is going to drive values and returns.”

Companies included in THG’s portfolio include cultivation and extraction company Jefferson Soul; two real estate holding companies Shasta Properties Management and Blue Sky Investments; plus three nutrient and fertilizer companies Kalix, NPK Industries, and Harvest Food for Life.

“This isn’t a starting point, it’s a launching pad and a breakthrough transaction that delivers on our team’s commitment to building out a fully integrated vertical cannabis platform,” Cox also stated. “It immediately unites several segment leaders into a powerful and flexible player in the legal cannabis market.”

“This kicks off our strategy of acquiring industry leaders in our focused verticals that can grow and expand with the management expertise and the capital we can inject as a public company,” Cox concluded. “The acquisition gives THCT a strong foundation for rapid growth and expansion within the cannabis markets as we continue to build a world-class portfolio of assets within the cannabis sectors.”

Reference

  1. THC Therapeutics, Inc. THC Therapeutics, Inc. Announces Acquisition of Oregon and California Consortium of Cannabis Companies https://www.globenewswire.com/news-release/2025/06/24/3104222/0/en/THC-Therapeutics-Inc-Announces-Acquisition-of-Oregon-and-California-Consortium-of-Cannabis-Companies.html (accessed Jun 25, 2025).

Related to this article

2025 Medical Cannabis Roundup
Let’s take a look at the 2025 cannabis coverage on medical cannabis research and medicine to catch up on industry trends and innovations.
Image | adobe.stock/Stock Rocket
Let’s take a look at the 2025 cannabis coverage on cannabis research to catch up on industry trends and innovations.
Manipulating Cannabis Genetics: Pulling Levers to Increase  Phytochemical Composition
Cannabis genetics fundamentally dictate the plant's potential for chemical signatures, including cannabinoid and terpene profiles, and physical traits, such as yield. Cultivators use selective techniques, such as "stacking," to enhance specific compounds. Ultimately, successful cultivation involves balancing superior genetics with environmental "levers" to optimize gene expression and create targeted strains.
Image | adobe.stock/Maksim Kabakou
It’s that time of year again—the Cannabis Science and Technology (CST) top 10 articles from the previous year. CST published a wide variety of content throughout 2025. Here is just a small snippet of some of the top articles that our readers enjoyed. See if any of your favorites made the list!